%0 Journal Article
%T Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue
%A Patrick Ch¨¨ne
%A Jo£żlle Rudloff
%A Joseph Schoepfer
%A Pascal Furet
%A Peter Meier
%A Zhiyan Qian
%A Jean-Marc Schlaeppi
%A Rita Schmitz
%A Thomas Radimerski
%J BMC Chemical Biology
%D 2009
%I BioMed Central
%R 10.1186/1472-6769-9-1
%X Here we describe the discovery and characterization of a novel purine diamine analogue as a potent ATP-competitive catalytic inhibitor of topoisomerase II. Quinoline aminopurine compound 1 (QAP 1) inhibited topoisomerase II ATPase activity and decatenation reaction at sub-micromolar concentrations, targeted both topoisomerase II alpha and beta in cell free assays and, using a quantitative cell-based assay and a chromosome segregation assay, displayed catalytic enzyme inhibition in cells. In agreement with recent hypothesis, we show that BRCA1 mutant breast cancer cells have increased sensitivity to QAP 1.The results obtained with QAP 1 demonstrate that potent and selective catalytic inhibition of human topoisomerase II function with an ATP-competitive inhibitor is feasible. Our data suggest that further drug discovery efforts on ATP-competitive catalytic inhibitors are warranted and that such drugs could potentially be developed as anti-cancer therapy for tumors that bear the appropriate combination of molecular alterations.Topoisomerase type II is an ATPase of the GHKL (gyrase, Hsp90, histidine kinase, MutL)-family that is evolutionary conserved in eukaryotes and essential for chromosome segregation during mitosis [1]. Mammals express two topoisomerase type II isoforms, alpha and beta, which are highly homologous but display differences in expression and in sub-cellular localization at the time of mitosis [2]. Like topoisomerases type I and III, the type II enzyme can remove topological constraints on DNA. However, it is the only enzyme that is capable of decatenating intertwined chromatids. Catenations in sister chromatids arise during DNA replication and must be removed to allow faithful chromosome segregation during anaphase [3]. Topoisomerase II is a homodimer that clamps onto two DNA double strands upon ATP binding to the amino-terminal ATPase domains. Subsequently, the enzyme transiently cleaves one of the DNA double strands and, using the energy derived from
%U http://www.biomedcentral.com/1472-6769/9/1